AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitalive M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Allysia Lifesciences Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitalive M 50mg/500mg Tablet

Combiflor 50mg/500mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Combiflor 50mg/500mg tablets may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual health status, blood sugar readings, and other medications. Taking this medication with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; patients must learn hypoglycemia recognition and management. This medication is not universally suitable. Prior to use, discuss any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption with your physician. Pregnant or lactating individuals require medical consultation. Inform your doctor of all concurrent medications to ensure safety and compatibility. Alcohol consumption should be minimized due to its hypoglycemic effects. Your physician will monitor kidney function and blood glucose levels throughout the treatment period.

Uses of Sitalive M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitalive M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitalive M 50mg/500mg Tablets should be administered with a meal.

Common Side effects of Sitalive M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalive M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitalive M 50mg/500mg Tablets should be administered with a meal.

How Sitalive M 50mg/500mg Tablet works:

Sitalive M, a 50mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Sitalive M 50mg/500mg Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitalive M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitalive M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitalive M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. Sitalive M 50mg/500mg tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Sitalive M 50mg/500mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitalive M 50mg/500mg Tablet :

Should you forget to take a Sitalive M 50mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalive M 50mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Diabetes medication

FAQs on Sitalive M 50mg/500mg Tablet

Sitalive M 50mg/500mg tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces liver glucose production and boosts insulin sensitivity. Sitagliptin blocks DPP-4, leading to increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged Sitalive M 50mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption in the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia and neurological issues, including peripheral paresthesia (tingling and numbness in extremities), weakness, urinary dysfunction, cognitive changes, and ataxia (balance difficulties). To mitigate these risks, supplemental Vitamin B12 intake, at minimum annually, is recommended by some experts.
Sitalive M 50mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitalive M 50mg/500mg Tablet constituents or inactive ingredients should not take this medication. Furthermore, its administration is contraindicated in individuals with severely compromised renal or hepatic function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitalive M 50mg/500mg Tablet is unsafe due to a heightened risk of lactic acidosis.
Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Sitalive M 50mg/500mg Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare side effect necessitates caution in patients with kidney impairment, advanced age, or significant alcohol consumption. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Sitalive M 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes in adults. This medication helps regulate blood sugar when used alongside a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and enhances insulin responsiveness, while sitagliptin's DPP-4 inhibition boosts pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalive M 50mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalive M 50mg/500mg Tablet ingredient or excipient should not use this medication. Its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalive M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of developing lactic acidosis.
Indeed, taking Sitalive M 50mg/500mg tablets carries a risk of lactic acidosis, a serious medical condition characterized by excessive lactic acid in the bloodstream. Also termed Metformin-associated lactic acidosis (MALA), this is a rare but significant complication of metformin use, prompting its avoidance in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms potentially indicating lactic acidosis include muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Sitalive M and seek immediate medical attention.
Prolonged Sitalive M 50mg/500mg Tablet use can indeed lead to vitamin B12 deficiency by hindering its gastric absorption. This deficiency, if left unaddressed, may result in anemia and neurological complications. Symptoms can include paresthesia in the extremities, general weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures, according to some studies, involve annual supplemental vitamin B12 intake.
Retain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medicine. Prevent access by children, pets, and others.
Sitalive M 50mg/500mg tablets contain sitagliptin and metformin, acting together to manage type 2 diabetes in adults. This medication enhances blood sugar control when combined with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin's mechanism involves DPP4 enzyme inhibition, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalive M 50mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalive M 50mg/500mg Tablet ingredient or additive should not use this medication. Its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalive M 50mg/500mg Tablet with alcohol is unsafe due to a heightened risk of lactic acidosis.
Indeed, Sitagliptin/Metformin 50mg/500mg tablets can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Presenting symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should any of these symptoms appear, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Prolonged Sitalive M 50mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia and neurological complications, including peripheral paresthesia (tingling and numbness in the extremities), muscle weakness, urinary dysfunction, cognitive changes, and gait instability (ataxia). To mitigate these risks, supplemental Vitamin B12 is recommended by some experts at least annually.
Retain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and other individuals.
Sitalive M 50mg/500mg Tab...
181
MRP 210
13% off